Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/kusuri-no-aoki-co-ltd">Kusuri No Aoki</a> is a rapidly expanding drugstore chain in Japan, differentiating itself with a 'Food &amp; Drug' one-stop-shop model that integrates pharmaceuticals with a strong and growing food offering, including fresh produce. This strategy drives high-frequency customer visits and has resulted in consistent double-digit revenue growth.</li>
  <li>Significant corporate governance concerns represent a major overhang on the stock. Issues highlighted by activist investor Oasis Management include controversial stock option issuances to the founding family, the adoption of a takeover defense mechanism, and a perceived lack of engagement with minority shareholders, which culminated in the company moving from the Tokyo Stock Exchange's Prime Market to the Standard Market.</li>
  <li>The competitive landscape is intensifying, particularly following the termination of its long-standing business and capital alliance with Aeon Co., Ltd.  Aeon, a major shareholder and competitor, is consolidating the drugstore market, posing a significant threat to the company's market share and profitability.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Kusuri No Aoki is a rapidly expanding drugstore chain in Japan, differentiating itself with a 'Food &amp; Drug' one-stop-shop model that integrates pharmaceuticals with a strong and growing food offering, including fresh produce. This strategy drives high-frequency customer visits and has resulted in consistent double-digit revenue growth.
  Significant corporate governance concerns represent a major overhang on the stock. Issues highlighted by activist investor Oasis Management include controversial stock option issuances to the founding family, the adoption of a takeover defense mechanism, and a perceived lack of engagement with minority shareholders, which culminated in the company moving from the Tokyo Stock Exchange's Prime Market to the Standard Market.
  The competitive landscape is intensifying, particularly following the termination of its long-standing business and capital alliance with Aeon Co., Ltd.  Aeon, a major shareholder and competitor, is consolidating the drugstore market, posing a significant threat to the company's market share and profitability.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Kusuri No Aoki (3398 JP) - Aug 2026

Japan

KUSURI NO AOKI CO., LTD. operates a drug store chain.  The Company sells medical drugs, cosmetics, toiletries, household and sundry goods, and groceries.  Some of their stores sell alcoholic beverages and frozen foods as well.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Kusuri No Aoki (3398 JP) - Aug 2026

Kusuri No Aoki is a rapidly expanding drugstore chain in Japan, differentiating itself with a 'Food & Drug' one-stop-shop model that...

αSK Primers